EJG Stock Overview
Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$19.00 |
| 52 Week High | NZ$22.60 |
| 52 Week Low | NZ$18.30 |
| Beta | 0.26 |
| 1 Month Change | -15.93% |
| 3 Month Change | -4.52% |
| 1 Year Change | -6.86% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| EJG | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.5% | -0.7% | -0.5% |
| 1Y | -6.9% | 42.9% | 15.5% |
Return vs Industry: EJG underperformed the German Healthcare industry which returned 38.1% over the past year.
Return vs Market: EJG underperformed the German Market which returned 13.8% over the past year.
Price Volatility
| EJG volatility | |
|---|---|
| EJG Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: EJG has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EJG's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 5,200 | John Cullity | www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
EBOS Group Limited Fundamentals Summary
| EJG fundamental statistics | |
|---|---|
| Market cap | €3.82b |
| Earnings (TTM) | €142.36m |
| Revenue (TTM) | €7.29b |
26.8x
P/E Ratio0.5x
P/S RatioIs EJG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EJG income statement (TTM) | |
|---|---|
| Revenue | AU$12.60b |
| Cost of Revenue | AU$10.99b |
| Gross Profit | AU$1.61b |
| Other Expenses | AU$1.36b |
| Earnings | AU$245.86m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.26 |
| Gross Margin | 12.78% |
| Net Profit Margin | 1.95% |
| Debt/Equity Ratio | 53.4% |
How did EJG perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield85%
Payout RatioDoes EJG pay a reliable dividends?
See EJG dividend history and benchmarks| EBOS Group dividend dates | |
|---|---|
| Ex Dividend Date | Feb 27 2025 |
| Dividend Pay Date | Mar 21 2025 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 6 days |
Does EJG pay a reliable dividends?
See EJG dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/13 11:34 |
| End of Day Share Price | 2025/03/13 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EBOS Group Limited is covered by 16 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |